Franklin Genomic Advancements ETF – AMEX:HELX

Franklin Genomic Advancements ETF stock price today

$29.277
+0.00
+0.02%

Franklin Genomic Advancements ETF stock price monthly change

-12.13%
month

Franklin Genomic Advancements ETF stock price quarterly change

-12.13%
quarter

Franklin Genomic Advancements ETF stock price yearly change

-4.75%
year

Franklin Genomic Advancements ETF key metrics

Market Cap
 10.81M
Enterprise value
 N/A
P/E
 N/A
EV/Sales
 N/A
EV/EBITDA
 N/A
Price/Sales
 N/A
Price/Book
 N/A
PEG ratio
 N/A
EPS
 N/A
Revenue
 N/A
EBITDA
 N/A
Income
 N/A
Revenue Q/Q
 N/A
Revenue Y/Y
 N/A
Profit margin
 0%
Oper. margin
 0%
Gross margin
 0%
EBIT margin
 0%
EBITDA margin
 N/A
Sign up &
create your own Smart Feed

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Sign up for free

Franklin Genomic Advancements ETF stock price history

Franklin Genomic Advancements ETF stock forecast

Franklin Genomic Advancements ETF financial statements

Franklin Genomic Advancements ETF other data

Franklin Genomic Advancements ETF
Latest News

Wednesday, 11 January 2023
Seeking Alpha
Saturday, 27 August 2022
Seeking Alpha
Friday, 10 June 2022
ETF Trends
Monday, 18 April 2022
ETF Trends

Frequently Asked Questions (FAQ)

  • What's the price of Franklin Genomic Advancements ETF stock today?

    One share of Franklin Genomic Advancements ETF stock can currently be purchased for approximately $29.28.

  • When is Franklin Genomic Advancements ETF's next earnings date?

    Unfortunately, Franklin Genomic Advancements ETF's (HELX) next earnings date is currently unknown.

  • Does Franklin Genomic Advancements ETF pay dividends?

    Yes, Franklin Genomic Advancements ETF pays dividends and its trailing 12-month yield is 0.11% with 0% payout ratio. The last Franklin Genomic Advancements ETF stock dividend of $0.05 was paid on 23 Dec 2020.

  • How much money does Franklin Genomic Advancements ETF make?

    Franklin Genomic Advancements ETF has a market capitalization of 10.81M.

  • What is Franklin Genomic Advancements ETF's stock symbol?

    Franklin Genomic Advancements ETF is traded on the AMEX under the ticker symbol "HELX".

  • What is Franklin Genomic Advancements ETF's primary industry?

    Company operates in the Financial Services sector and Asset Management industry.

  • How do i buy shares of Franklin Genomic Advancements ETF?

    Shares of Franklin Genomic Advancements ETF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

  • When Franklin Genomic Advancements ETF went public?

    Franklin Genomic Advancements ETF is publicly traded company for more then 5 years since IPO on 27 Feb 2020.

Franklin Genomic Advancements ETF company profile:

Franklin Genomic Advancements ETF

Exchange:

AMEX

Full time employees:

0

Industry:

Asset Management

Sector:

Financial Services

Under normal market conditions, the fund invests at least 80% of its net assets in equity securities of companies that are relevant to its investment theme of genomic advancements. The fund invests predominantly in common stock. Although it may invest across economic sectors, the fund concentrates its investments in health care related industries. It is non-diversified.


,

CIK: 0001655589
ISIN: US35473P5200
CUSIP: 35473P520